NPKI vs ECG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 04, 2026

NPKI

31.5
AI Score
VS
ECG Wins

ECG

57.7
AI Score

Investment Advisor Scores

NPKI

32score
Recommendation
AVOID NEW MONEY

ECG

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NPKI ECG Winner
Forward P/E 14.8368 16.1031 NPKI
PEG Ratio 1.3046 0 Tie
Revenue Growth 10.8% 33.7% ECG
Earnings Growth 3.4% 59.2% ECG
Tradestie Score 31.5/100 57.7/100 ECG
Profit Margin 14.0% 6.0% NPKI
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD ECG

Relative Price Performance (Last 90 Days)

NPKI 1M: -17.1% · 3M: -32.4% ECG 1M: -24.7% · 3M: -35.2%

Current Technical Phase

NPKI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.0%), weak momentum, RSI 36

RSI (14): 35.5 · Price: $9.36

ECG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.3%), weak momentum, RSI 42

RSI (14): 42.0 · Price: $89.11

Fundamentals Snapshot

Metric NPKI ECG
Market Cap — —
Forward P/E 15.3 12.7
Trailing P/E 19.7 14.9
Revenue (TTM) — —
Revenue Growth 0.1% 0.4%
Gross Margin 0.4% 0.1%
Operating Margin 0.1% 0.1%
EPS 0.46 5.74
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ECG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.